ALT5 Sigma Second Quarter 2025 Earnings: US$0.30 loss per share (vs US$0.12 profit in 2Q 2024)

Simply Wall St

August 15, 2025

NasdaqCM:ALTS 1 Year Share Price vs Fair Value

Explore ALT5 Sigma's Fair Values from the Community and select yours

ALT5 Sigma (NASDAQ:ALTS) Second Quarter 2025 Results

Key Financial Results

Revenue: US$6.38m (up 194% from 2Q 2024).
Net loss: US$5.50m (down from US$970.0k profit in 2Q 2024).
US$0.30 loss per share (down from US$0.12 profit in 2Q 2024).

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

earnings-and-revenue-growth — NasdaqCM:ALTS Earnings and Revenue Growth August 15th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

ALT5 Sigma Earnings Insights

Looking ahead, revenue is forecast to grow 35% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Pharmaceuticals industry in the US.

Performance of the American Pharmaceuticals industry.

The company's shares are down 12% from a week ago.

Risk Analysis

It is worth noting though that we have found 3 warning signs for ALT5 Sigma (2 make us uncomfortable!) that you need to take into consideration.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.